Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Precision Medicine in Infectious Disease Publisher



Alvarez MJR1 ; Hasanzad M2, 3 ; Sarhangi N3 ; Meybodi HRA4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Istituto Superiore di Sanita, Rome, Italy
  2. 2. Medical Genomics Research Center, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  3. 3. Personalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Precision Medicine in Clinical Practice Published:2022


Abstract

The conception that several infectious diseases were linked to an inherited disorder has been discussed, and every day, substantial evidence now is supported by the human genetic contribution to susceptibility to infectious diseases. Despite being a forerunner, personalized medicine (PM) is not yet routinely applied in infectious patient care. For this scope, education is a crucial step for the successful implementation of PM in the clinic, and with this part, we would like to encourage learning about PM in the communicable disease field. The information in this section will drive you through the concept of personalized infectious diseases and a piece of basic knowledge about the possibility of identifying determinants of clinical outcomes, looking at the host face through selected infectious diseases which are considered a global health issue such as HIV (human immunodeficiency virus) infection and related AIDS (acquired immunodeficiency syndrome), infections caused by Mycobacterium tuberculosis, malaria, and COVID-19 infection. It is especially important, as it can enable the development of one’s own thoughts and ideas to be able to understand and implement this rapidly developing field of science. A brief overview of the genetic identification of more vulnerable individuals is expected to inform personalized treatment and perhaps vaccination strategies. Additionally, new technologies are supporting the rapid identification of infective agents and targeted approaches based on the genetic resistance of pathogens to antibiotics. This information can lead to revising the data that can be used for personalized predicting diseases, improving personalized treatment, and also personalized prevention strategies specific to infectious pathogens. The last subchapter is dedicated to a deeper revision of the COVID-19 infection from a personalized medicine perspective. © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2022.
Related Docs
View other Related Docs
1. Sars-Cov-2: A Comprehensive Review From Pathogenicity of the Virus to Clinical Consequences, Journal of Medical Virology (2020)
2. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
3. Sars-Cov-2: From the Pathogenesis to Potential Anti-Viral Treatments, Biomedicine and Pharmacotherapy (2021)
4. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
5. The Situation of Small Molecules Targeting Key Proteins in Combatting Sars-Cov-2: Synthesis, Metabolic Pathway, Mechanism of Action, and Potential Therapeutic Applications, Mini-Reviews in Medicinal Chemistry (2022)
6. Introduction on Coronavirus Disease (Covid-19) Pandemic: The Global Challenge, Advances in Experimental Medicine and Biology (2021)
7. Serological and Molecular Tests for Covid-19: A Recent Update, Iranian Journal of Immunology (2021)
8. Crispr/Cas13: A Potential Therapeutic Option of Covid-19, Biomedicine and Pharmacotherapy (2020)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (30)
Seyed Ahmad Seyed Alinaghi (7)
Other Related Docs
9. Covid-19: Review of a 21St Century Pandemic From Etiology to Neuro-Psychiatric Implications, Journal of Alzheimer's Disease (2020)
10. Coronavirus: Pure Infectious Disease or Genetic Predisposition, Advances in Experimental Medicine and Biology (2021)
11. Variable Clinical Manifestations of Covid-19: Viral and Human Genomes Talk, Iranian Journal of Allergy# Asthma and Immunology (2020)
12. Current Treatments and Therapeutic Options for Covid-19 Patients: A Systematic Review, Infectious Disorders - Drug Targets (2022)
13. Remdesivir: A Beacon of Hope From Ebola Virus Disease to Covid-19, Reviews in Medical Virology (2020)
14. Targeted Therapy Strategies Against Sars-Cov-2 Cell Entry Mechanisms: A Systematic Review of in Vitro and in Vivo Studies, Journal of Cellular Physiology (2021)
15. Vlp-Based Covid-19 Vaccines: An Adaptable Technology Against the Threat of New Variants, Vaccines (2021)
16. The Clinical Value of Two Combination Regimens in the Management of Patients Suffering From Covid-19 Pneumonia: A Single Centered, Retrospective, Observational Study, DARU# Journal of Pharmaceutical Sciences (2020)
17. Ten Challenging Questions About Sars-Cov-2 and Covid-19, Expert Review of Respiratory Medicine (2020)
18. Severe Acute Respiratory Syndrome-Coronavirus-2 Spike (S) Protein Based Vaccine Candidates: State of the Art and Future Prospects, Reviews in Medical Virology (2021)
19. Covid-19: A Systematic Review and Update on Prevention, Diagnosis, and Treatment, MedComm (2022)
20. Immunopathological Similarities Between Covid-19 and Influenza: Investigating the Consequences of Co-Infection, Microbial Pathogenesis (2021)
21. Immune-Based Therapy for Covid-19, Advances in Experimental Medicine and Biology (2021)
22. Design of Novel Disturbing Peptides Against Ace2 Sars-Cov-2 Spike-Binding Region by Computational Approaches, Frontiers in Pharmacology (2022)
23. Existing Antiviral Options Against Sars-Cov-2 Replication in Covid-19 Patients, Future Microbiology (2020)
24. Evolutionary Study of Covid-19, Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) As an Emerging Coronavirus: Phylogenetic Analysis and Literature Review, Veterinary Medicine and Science (2021)
25. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)
26. Corona Virus Disease 2019 (Covid-19) As a System-Level Infectious Disease With Distinct Sex Disparities, Frontiers in Immunology (2021)
27. A Borderless Solution Is Needed for a Borderless Complexity, Like Covid-19, the Universal Invader, Advances in Experimental Medicine and Biology (2021)
28. Host Factors: Implications in Immunopathogenesis of Covid-19, Pathology Research and Practice (2021)
29. Therapeutic Potentials and Candidates for Covid-19, Iranian Journal of Science (2023)
30. Being a Front-Line Dentist During the Covid-19 Pandemic: A Literature Review, Maxillofacial Plastic and Reconstructive Surgery (2020)
31. Sars-Cov-2 Outbreak in Iran: The Dynamics of the Epidemic and Evidence on Two Independent Introductions, Transboundary and Emerging Diseases (2022)
32. Efficacy and Safety of Sofosbuvir/ Ledipasvir in Treatment of Patients With Covid-19; a Randomized Clinical Trial, Acta Biomedica (2020)
33. Variants in Ace2; Potential Influences on Virus Infection and Covid-19 Severity, Infection# Genetics and Evolution (2021)
34. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
35. Classification of the Present Pharmaceutical Agents Based on the Possible Effective Mechanism on the Covid-19 Infection, DARU# Journal of Pharmaceutical Sciences (2020)
36. Can Anti-Parasitic Drugs Help Control Covid-19?, Future Virology (2022)
37. Therapeutic and Diagnostic Applications of Nanoparticles in the Management of Covid-19: A Comprehensive Overview, Virology Journal (2022)
38. Comparison of Sars-Cov-2 (Coronavirus) With Other Similar Viruses Based on Current Evidence, Journal of Iranian Medical Council (2022)
39. Comparison of Immune Response Between Sars, Mers, and Covid-19 Infection, Perspective on Vaccine Design and Development, BioMed Research International (2021)
40. Sars-Cov-2 Nucleocapsid: Biological Functions and Implication for Disease Diagnosis and Vaccine Design, Reviews in Medical Virology (2023)
41. A Review of Covid-19: The Main Ways of Transmission and Some Prevention Solutions, Clinical Symptoms, More Vulnerable Human Groups, Risk Factors, Diagnosis, and Treatment, Journal of Environmental Treatment Techniques (2020)
42. State-Of-The-Art of Nanodiagnostics and Nanotherapeutics Against Sars-Cov-2, ACS Applied Materials and Interfaces (2021)
43. A Comprehensive Review of Histopathological Findings of Infections Induced by Covid-19, Cellular and Molecular Biology (2020)
44. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
45. Covid-19: Transmission, Prevention, and Potential Therapeutic Opportunities, Clinica Chimica Acta (2020)
46. Naringenin, a Flavanone With Antiviral and Anti-Inflammatory Effects: A Promising Treatment Strategy Against Covid-19, Phytotherapy Research (2020)
47. A Review on an Ongoing Pandemic Caused by the Severe Acute Respiratory Syndrome Coronavirus 2: The Pathogenesis, Epidemiology, Immunological Features, and Currently Available Diagnostic Tests, Reviews and Research in Medical Microbiology (2022)
48. Targeting the Vital Non-Structural Proteins (Nsp12, Nsp7, Nsp8 and Nsp3) From Sars-Cov-2 and Inhibition of Rna Polymerase by Natural Bioactive Compound Naringenin As a Promising Drug Candidate Against Covid-19, Journal of Molecular Structure (2023)
49. A Review on the Mechanisms Involved in the Immunopathogenesis of Sars-Cov-2, Journal of Military Medicine (2020)
50. Covid-19 and Multiorgan Failure: A Narrative Review on Potential Mechanisms, Journal of Molecular Histology (2020)